BGM
IMRX icon

Burkehill Global Management’s Immuneering IMRX Stock Holding History

Burkehill Global Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Hold
300,000
– – 0.05% 141
2026
Q1 		$1.58M Hold
300,000
– – 0.08% 140
2025
Q4 		$1.97M Hold
300,000
– – 0.13% 120
2025
Q3 		$2.1M Buy
+300,000
New +$1.56M 0.12% 115

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Burkehill Global Management's IMRX Position: Q2 2026 in Review

Burkehill Global Management held its Immuneering (IMRX) position steady in Q2 2026 at 300,000 shares worth $1.5M. The position accounts for 0.05% of the portfolio, ranked #141.

Burkehill Global Management first reported a position in IMRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.1M in Q3 2025. 112 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Burkehill Global Management held 300,000 shares of Immuneering worth $1.5M as of Q2 2026.
  • Burkehill Global Management left its Immuneering share count unchanged in Q2 2026.
  • Immuneering made up 0.05% of Burkehill Global Management's portfolio in Q2 2026, its #141 holding.
  • Burkehill Global Management first reported a position in Immuneering in Q3 2025 and has held it in 4 quarters since.
  • Burkehill Global Management's Immuneering position peaked at $2.1M in Q3 2025.
  • 112 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.